Culture and sensitivity of mycobacterial isolates from cases of pulmonary tuberculosis classified as treatment failures in a teaching hospital

West African Journal of Medicine

Volumn 26, Issue 2, 2007, Pages 131-133

  Newman, Mercy J ^a   Addo, K K ^d   Aboagye, S ^b   Bonsu, F A ^e   Caulley, P ^c   Hesse, I F A ^a   Neequaye, A R ^a   Kudzawu, S ^b  

^a UNIVERSITY OF GHANA   (Ghana)

^b KORLE BU TEACHING HOSPITAL   (Ghana)

^c Public Health Reference Laboratory

^d University of Ghana

^e National Tuberculosis Control Programme   (Tanzania)

Author keywords

Ghana; Multiple drug resistance; Mycobacteria; Pulmonary tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG MONITORING; DRUG TREATMENT FAILURE; FEMALE; FUNGUS GROWTH; GHANA; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPUTUM EXAMINATION; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, BACTERIAL; FEMALE; GHANA; HEALTH SURVEYS; HOSPITALS, TEACHING; HUMANS; MALE; MYCOBACTERIUM; PROSPECTIVE STUDIES; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY;

EID: 34848833811     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Hlth Org 1994; 72: 213-220.
2. Raviglione MR, Snider DE, Kochi A. Global epidemiology of tuberculosis - morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
3. World Health Organization, Global Tuberculosis Report, 2005.
4. Crofton J, Mitchison DA. Streptomycin resistance in pulmonary tuberculosis BMJ 1948; 2: 1009-1015.
5. Goble M, Iseman MD, Madsen LA Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Engl J Med 1993; 328: 527-532.
6. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1994; 144: 104-110.
7. Drobniewski F. Antimicrobial susceptibility testing of Mycobacterium tuberculosis. European Society of Microbiology and Infectious Disease CMI,8. (2001) pp 1-10
8. Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In Hatfull GH, Jacobs, Jr. WR (eds), Molecular genetics of Mycobacteria. pp. 235-254 (2000). ASM Press, Washington, D.C.
9. Toyota E, Sekiguchi J, Shimizu H. Further acquisition of drug resistance in multi-drug resistant tuberculosis during chemotherapy. Jp J of Inf Dis 2004; 57: 292-294
10. Bonsu F A. Guidelines for managing tuberculosis in health facilities. National Tuberculosis Control Programme (MOH) 2003
11. Grange JM, Yates MD. Guidelines for speciation within the Mycobacterium tuberculosis complex. World Health Organization/Zoonosis. 1994; 174: 1-14.
12. Canetti G, Fox W, Khomenko A. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO1969; 41: 21-43.
13. Pablos -Mendez A, Raviglione MC, Laszlo A. I Global surveillance for antituberculosis-drug resistance 1994-1997. N. Engl J Med 1998; 338: 1641-1649.
14. Bell WJ, Brown PP. Bacteria resistance in patients with pulmonary tuberculosis presenting for treatment in Ghana. Bri J Dis. Chest 1961; 55: 192-199.
15. Sodhi HS, Salles CA. Drug resistance of tubercle bacilli isolated in Accra. Ghana Med J 1966; 5: 44-47
16. Van der Werf TS, Groothuis DG, van Kingeren B. High initial drug resistance in pulmonary tuberculosis in Ghana. Tubercule. 1989; 70: 249-255.
17. Lawn SD, Frimpong EH, Al-Ghusein H. Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. West Afr J Med 2001; 20: 92-97.
18. Bastian I, Colebunders R. Treatment and prevention of multidrug-rcsistant tuberculosis. Drugs 1999; 58: 633-661.